Annotation Detail

Information
Associated Genes
MET
Associated Variants
MET MUTATION
MET MUTATION
Associated Disease
Non-small cell lung carcinoma
Source Database
DisGeNET
Description
Expression of the oncogene hepatocyte growth factor receptor (MET) and phosphorylation of the MET protein have been associated with both primary and acquired resistance to tyrosine kinase inhibitors (TKIs) used in therapy targeting the epidermal growth factor receptor (EGFR) in patients with non-small cell lung cancers (NSCLCs).
Pubmed
25522678
Section of the abstract supporting the evidence
ALL_TEXT_1/3
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
1
Original source reporting the Gene Disease association
BeFree,CTD_human
DisGENET score for the Gene Disease association
0.141443907894344
Drugs